Quantum BioPharma Reports Third Quarter Non-GAAP EPS of -$0.06
Quantum BioPharma (QNTM) has released its financial results for the third quarter ending September 30, 2026. The company reported a non-GAAP earnings per share (EPS) of -$0.06. Despite the quarterly loss, the company showed significant growth in its liquidity position. Cash and cash equivalents rose to $3,556,345, representing an 87% increase from the $1,905,357 reported as of December 31, 2025.
Tickers: $QNTM
Topics: cash flow earnings report non-GAAP EPS